Halozyme Therapeutics Inc. (NASDAQ: HALO): Is It A Buying Opportunity Again?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Halozyme Therapeutics Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Halozyme Therapeutics Inc. is $5.55B. A total of 0.9 million shares were traded on the day, compared to an average of 1.03M shares.

In the most recent transaction, LaBarre Michael J. sold 10,000 shares of HALO for 38.49 per share on Apr 17 ’24. After the transaction, the SVP, CHIEF TECHNICAL OFFICER now owns 168,176 company shares. In a previous transaction on Apr 16 ’24, LaBarre Michael J. sold 10,000 shares at 38.35 per share. HALO shares that SVP, CHIEF TECHNICAL OFFICER owns now total 168,176.

Among the insiders who sold shares, LaBarre Michael J. disposed of 10,000 shares on Mar 13 ’24 at a per-share price of $42.27. This resulted in the SVP, CHIEF TECHNICAL OFFICER holding 156,558 shares of HALO after the transaction. In another insider transaction, LaBarre Michael J. sold 10,000 shares at $41.64 per share on Mar 12 ’24. Company shares held by the SVP, CHIEF TECHNICAL OFFICER now total 156,558.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, HALO has a high of $45.00 and a low of $31.86.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. HALO’s latest balance sheet shows that the firm has $740.92M in Cash & Short Term Investments as of fiscal 2021. There were $876.67M in debt and $117.15M in liabilities at the time. Its Book Value Per Share was $1.40, while its Total Shareholder’s Equity was $196.95M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HALO is Buy with a score of 4.60.

Most Popular

Related Posts